Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00210639 · ClinicalTrials.gov registry record
A Study of Incidence of Musculoskeletal Disorders in Children Who Have Received Levofloxacin or a Standard Non-Fluoroquinolone Therapy for Acute Bacterial Infection
A clinical trial, sponsored by Johnson & Johnson Pharmaceutical Research & Development, L.L.C..
- Completed
- Registry status
- 2,233
- Enrollment target
NCT00210639 is a clinical trial that has completed, run by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.. The registered enrollment target is 2,233 participants.
The verdict
NCT00210639 has completed, sponsored by Johnson & Johnson Pharmaceutical Research & Development, L.L.C..
- COMPLETED
- Registry status
- 2,233 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the long-term safety of levofloxacin administered to children as therapy for acute bacterial infection.
Interventions
- DRUG No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,233 participants |
| Start Date | 2002-08 |
| Est. Completion | 2010-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00210639
The ClinicalTrials.gov registry entry for NCT00210639 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,233 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Pharmaceutical Research & Development, L.L.C., which has 102 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT00210639 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00210639 about?
NCT00210639 is a clinical study titled "A Study of Incidence of Musculoskeletal Disorders in Children Who Have Received Levofloxacin or a Standard Non-Fluoroquinolone Therapy for Acute Bacterial Infection". The purpose of this study is to assess the long-term safety of levofloxacin administered to children as therapy for acute bacterial infection.
What is the current status of trial NCT00210639?
This trial is currently completed. The enrollment target is 2,233 participants. The study started on 2002-08. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00210639?
The interventions under investigation include: No intervention (DRUG).
Who is sponsoring clinical trial NCT00210639?
This trial is sponsored by Johnson & Johnson Pharmaceutical Research & Development, L.L.C., which has 102 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.